CClinicalTrials.gg
Status unknownNCT05668052Updated Dec 29, 2022

A Cross-sectional Study of Covid-19 Pandemic in Zhejiang Province

An observational study in Cross-sectional Study and COVID-19 Pandemic, sponsored by The First Affiliated Hospital of Zhejiang Chinese Medical University. Status unknown. Per ClinicalTrials.gov, last updated 2022-12-29.

Sponsored by The First Affiliated Hospital of Zhejiang Chinese Medical University · Observational

The sponsor has not verified this record recently (last verified Dec 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
500
Sex
All
01

Study summary

this study adopted a cross-sectional study, collected the medical history and symptoms of patients infected with Covid-19 through a questionnaire survey, and made statistical analysis, so as to provide better clinical guidance.

Read the detailed description

Recently, there has been an outbreak of covid-19 in Zhejiang Province. In order to comprehensively understand the condition of patients with covid-19 in Zhejiang Province, this study adopted a cross-sectional study, collected the medical history and symptoms of patients infected with Covid-19 through a questionnaire survey, and made statistical analysis, so as to provide better clinical guidance.

02

Conditions studied

  • Cross-sectional Study
  • COVID-19 Pandemic

Browse trials for

Keywords

  • Cross-sectional study
  • COVID-19 Pandemic
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's planned enrollment of 500 is above the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

The First Affiliated Hospital of Zhejiang Chinese Medical University is the lead sponsor of 37 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

patients with Covid-19

Inclusion criteria

  • A positive nucleic acid test for Covid-19, or a positive antigen test for novel coronavirus, no age limit.

Exclusion criteria

Exclusion Criteria:

  • Unable to understand the contents of the questionnaire for various reasons
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
500 participants (estimated)
Patient registry
No

Interventions

  • Otherquestionnaire

    This survey was conducted in Zhejiang Provincial Hospital of Traditional Chinese Medicine from December 2022 to December 2023. The research objects were patients with COVID-19.

06

What researchers measure

Primary outcomes

  1. characters of patients with Covid-19

    this study collected the medical history and symptoms of patients infected with Covid-19 through a questionnaire survey, and made statistical analysis

    Time frame: baseline

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 29, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05668052
Lead sponsor
The First Affiliated Hospital of Zhejiang Chinese Medical University
Responsible party
Sponsor
First posted
Dec 29, 2022
Start date
Dec 27, 2022 (estimated)
Primary completion
Dec 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Dec 29, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion